Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lymphoma 138Lymphoma, Non-Hodgkin 84Lymphoma, Large B-Cell, Diffuse 83Small Cell Lung Carcinoma 78Hodgkin Disease 61Precursor Cell Lymphoblastic Leukemia-Lymphoma 59Leukemia 57Burkitt Lymphoma 56Lung Neoplasms 49Lymphoma, Follicular 47Lymphoma, Mantle-Cell 44Leukemia, Myeloid, Acute 41Lymphoma, Large-Cell, Immunoblastic 40Multiple Myeloma 33Leukemia, Lymphocytic, Chronic, B-Cell 33Carcinoma, Non-Small-Cell Lung 30Recurrence 26Neuroblastoma 25Lymphoma, B-Cell, Marginal Zone 25Central Nervous System Neoplasms 24Ovarian Neoplasms 18Sarcoma 17Brain Neoplasms 17Dendritic Cell Sarcoma, Interdigitating 16Congenital Abnormalities 16Lymphoma, Large-Cell, Anaplastic 15Breast Neoplasms 15Testicular Neoplasms 14Neoplasms, Plasma Cell 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13

Interventions

Carboplatin 6durvalumab 3atezolizumab 3Paclitaxel 2Bevacizumab 2toripalimab 1sintilimab 1pegylated granulocyte colony-stimulating factor 1necitumumab 1ceralasertib 1cemiplimab 1apatinib 1alectinib 1Radiotherapy 1Radiosurgery 1Pemetrexed 1Gemcitabine 1Etoposide 1Erlotinib Hydrochloride 1Cisplatin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Thoracic Neoplasms × Etoposide × Clear all
NCT06177925 2023-12-20

A Phase â…¡ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC

Nanfang Hospital, Southern Medical University

Phase 2 Recruiting
62 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡